HHS Proposes Major Updates to Testosterone Therapy Labels
The Department of Health and Human Services (HHS) has announced plans to revise labeling for testosterone replacement therapy (TRT) products, a move that could enhance access for men experiencing idiopathic and age-related hypogonadism. This change aims to reflect the latest scientific research regarding the safety and effectiveness of TRT, according to HHS Secretary Robert F….
